Fujiwara, K.; Sasawatari, S.; Nakai, S.; Imaeda, K.; Nagai, S.; Matsuno, Y.; Hatanaka, K.; Hatanaka, Y.; Takenaka, S.; Okada, N.
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients. Cancers 2020, 12, 2735.
https://doi.org/10.3390/cancers12102735
AMA Style
Fujiwara K, Sasawatari S, Nakai S, Imaeda K, Nagai S, Matsuno Y, Hatanaka K, Hatanaka Y, Takenaka S, Okada N.
Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients. Cancers. 2020; 12(10):2735.
https://doi.org/10.3390/cancers12102735
Chicago/Turabian Style
Fujiwara, Kento, Shigemi Sasawatari, Sho Nakai, Keisuke Imaeda, Seina Nagai, Yoshihiro Matsuno, Kanako Hatanaka, Yutaka Hatanaka, Satoshi Takenaka, and Naoki Okada.
2020. "Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients" Cancers 12, no. 10: 2735.
https://doi.org/10.3390/cancers12102735
APA Style
Fujiwara, K., Sasawatari, S., Nakai, S., Imaeda, K., Nagai, S., Matsuno, Y., Hatanaka, K., Hatanaka, Y., Takenaka, S., & Okada, N.
(2020). Predicting the Efficacy and Safety of TACTICs (Tumor Angiogenesis-Specific CAR-T Cells Impacting Cancers) Therapy for Soft Tissue Sarcoma Patients. Cancers, 12(10), 2735.
https://doi.org/10.3390/cancers12102735